TALIS BIOMEDICAL CORP
Held by 1 superinvestor (TLIS). Valuation data coming soon.
Educational data only — not investment advice. 13F positions are self-reported and can lag up to 45 days.
Superinvestors Holding This Security
| Investor | Value | Shares | Weight |
|---|---|---|---|
| David Einhorn | $1.1M | 149,052 | 0.05% |
Stock valuation (intrinsic value / DCF) coming soon.
Sources·SEC EDGAR 13F as of 2024-02-14
Related